Literature DB >> 9990086

Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice.

J Gomeza1, H Shannon, E Kostenis, C Felder, L Zhang, J Brodkin, A Grinberg, H Sheng, J Wess.   

Abstract

Members of the muscarinic acetylcholine receptor family (M1-M5) are known to be involved in a great number of important central and peripheral physiological and pathophysiological processes. Because of the overlapping expression patterns of the M1-M5 muscarinic receptor subtypes and the lack of ligands endowed with sufficient subtype selectivity, the precise physiological functions of the individual receptor subtypes remain to be elucidated. To explore the physiological roles of the M2 muscarinic receptor, we have generated mice lacking functional M2 receptors by using targeted mutagenesis in mouse embryonic stem cells. The resulting mutant mice were analyzed in several behavioral and pharmacologic tests. These studies showed that the M2 muscarinic receptor subtype, besides its well documented involvement in the regulation of heart rate, plays a key role in mediating muscarinic receptor-dependent movement and temperature control as well as antinociceptive responses, three of the most prominent central muscarinic effects. These results offer a rational basis for the development of novel muscarinic drugs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9990086      PMCID: PMC15563          DOI: 10.1073/pnas.96.4.1692

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  The central action of a metabolite of tremorine.

Authors:  R GEORGE; W L HASLETT; D J JENDEN
Journal:  Life Sci (1962)       Date:  1962-08

2.  Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies.

Authors:  A I Levey; C A Kitt; W F Simonds; D L Price; M R Brann
Journal:  J Neurosci       Date:  1991-10       Impact factor: 6.167

Review 3.  Muscarinic receptor subtypes.

Authors:  E C Hulme; N J Birdsall; N J Buckley
Journal:  Annu Rev Pharmacol Toxicol       Date:  1990       Impact factor: 13.820

4.  Tertiary 3- and 4-haloalkylamine analogues of oxotremorine as prodrugs of potent muscarinic agonists.

Authors:  B Ringdahl; M Roch; D J Jenden
Journal:  J Med Chem       Date:  1988-01       Impact factor: 7.446

5.  Antinociception opioids and the cholinergic system.

Authors:  P G Green; I Kitchen
Journal:  Prog Neurobiol       Date:  1986       Impact factor: 11.685

6.  Localization of a family of muscarinic receptor mRNAs in rat brain.

Authors:  N J Buckley; T I Bonner; M R Brann
Journal:  J Neurosci       Date:  1988-12       Impact factor: 6.167

7.  Muscarinic actions of an N-methyl-N-2-bromoethylamino analog of oxotremorine (BR 401) in the mouse.

Authors:  B Ringdahl; D J Jenden
Journal:  J Pharmacol Exp Ther       Date:  1987-02       Impact factor: 4.030

8.  Antinociceptive effects of intrathecally injected cholinomimetic drugs in the rat and cat.

Authors:  T L Yaksh; R Dirksen; G J Harty
Journal:  Eur J Pharmacol       Date:  1985-10-29       Impact factor: 4.432

Review 9.  Cholinergic mechanisms in pain and analgesia.

Authors:  P Hartvig; P G Gillberg; T Gordh; C Post
Journal:  Trends Pharmacol Sci       Date:  1989-12       Impact factor: 14.819

10.  Antagonist binding profiles of five cloned human muscarinic receptor subtypes.

Authors:  F Dörje; J Wess; G Lambrecht; R Tacke; E Mutschler; M R Brann
Journal:  J Pharmacol Exp Ther       Date:  1991-02       Impact factor: 4.030

View more
  103 in total

1.  Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice.

Authors:  J Gomeza; L Zhang; E Kostenis; C Felder; F Bymaster; J Brodkin; H Shannon; B Xia; C Deng; J Wess
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

2.  Biphasic, opposing modulation of cloned neuronal alpha1E Ca channels by distinct signaling pathways coupled to M2 muscarinic acetylcholine receptors.

Authors:  U Meza; R Bannister; K Melliti; B Adams
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

3.  Delineating muscarinic receptor functions.

Authors:  R R Gainetdinov; M G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  Cholinergic dilation of cerebral blood vessels is abolished in M(5) muscarinic acetylcholine receptor knockout mice.

Authors:  M Yamada; K G Lamping; A Duttaroy; W Zhang; Y Cui; F P Bymaster; D L McKinzie; C C Felder; C X Deng; F M Faraci; J Wess
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

5.  Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice.

Authors:  Weilie Zhang; Anthony S Basile; Jesus Gomeza; Laura A Volpicelli; Allan I Levey; Jürgen Wess
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

6.  Excitatory nicotinic and desensitizing muscarinic (M2) effects on C-nociceptors in isolated rat skin.

Authors:  N Bernardini; S K Sauer; R Haberberger; M J Fischer; P W Reeh
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

Review 7.  Use of M1-M5 muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic system.

Authors:  Frank P Bymaster; David L McKinzie; Christian C Felder; Jürgen Wess
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

8.  Presynaptic muscarinic M(2) receptors modulate glutamatergic transmission in the bed nucleus of the stria terminalis.

Authors:  Ji-Dong Guo; Rimi Hazra; Joanna Dabrowska; E Chris Muly; Jürgen Wess; Donald G Rainnie
Journal:  Neuropharmacology       Date:  2011-12-08       Impact factor: 5.250

9.  A pervasive mechanism for analgesia: activation of GIRK2 channels.

Authors:  Y A Blednov; M Stoffel; H Alva; R A Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-19       Impact factor: 11.205

10.  Role of presynaptic muscarinic and GABA(B) receptors in spinal glutamate release and cholinergic analgesia in rats.

Authors:  De-Pei Li; Shao-Rui Chen; Yu-Zhen Pan; Allan I Levey; Hui-Lin Pan
Journal:  J Physiol       Date:  2002-09-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.